Biochemical and anatomical redistribution of tau protein in Alzheimer's disease
- PMID: 8342603
- PMCID: PMC1887045
Biochemical and anatomical redistribution of tau protein in Alzheimer's disease
Abstract
We have developed assays that distinguish tau protein incorporated into the core structure of the paired helical filament (PHF) from non-PHF tau protein in brain tissue, whether soluble or insoluble. The PHF content was 19-fold greater in Alzheimer's disease cases compared with cognitively intact controls, and in temporal cortex the difference was 40-fold. There was a threefold decrease in soluble tau protein in Alzheimer's disease cases compared with normal age-matched controls, the decrease being greatest in frontal cortex. The PHF content was closely correlated with the number of tau-immunoreactive dystrophic neurites in plaques and throughout the neuropil, whereas counts of neurofibrillary tangles were poorer predictors of PHF content. beta-Amyloid deposits correlated neither with PHF content nor with neurofibrillary pathology. These findings suggest that Alzheimer's disease is characterized by a substantial redistribution of available tau protein from free to PHF-incorporated fractions and that PHF accumulation may be important in neurites as well as tangles in predicting the extent of cognitive impairment in Alzheimer's disease.
Similar articles
-
Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.J Comp Neurol. 1993 Aug 8;334(2):176-91. doi: 10.1002/cne.903340203. J Comp Neurol. 1993. PMID: 7690048
-
Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.Arzneimittelforschung. 1995 Mar;45(3A):403-9. Arzneimittelforschung. 1995. PMID: 7763334 Review.
-
Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.Neuropathol Appl Neurobiol. 2005 Aug;31(4):414-21. doi: 10.1111/j.1365-2990.2005.00663.x. Neuropathol Appl Neurobiol. 2005. PMID: 16008825
-
Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers.Brain. 2010 Dec;133(Pt 12):3685-98. doi: 10.1093/brain/awq263. Brain. 2010. PMID: 21126996
-
[Tau, amyloid and Alzheimer's disease].Ugeskr Laeger. 1994 Feb 21;156(8):1116-7, 1121-4. Ugeskr Laeger. 1994. PMID: 8116089 Review. Danish.
Cited by
-
Untangling tau imaging.Alzheimers Dement (Amst). 2016 Jun 4;4:39-42. doi: 10.1016/j.dadm.2016.05.001. eCollection 2016. Alzheimers Dement (Amst). 2016. PMID: 27489878 Free PMC article. Review.
-
Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease.Am J Pathol. 2000 Aug;157(2):623-36. doi: 10.1016/s0002-9440(10)64573-7. Am J Pathol. 2000. PMID: 10934165 Free PMC article.
-
Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration.Am J Pathol. 2009 Oct;175(4):1598-609. doi: 10.2353/ajpath.2009.090462. Epub 2009 Aug 28. Am J Pathol. 2009. PMID: 19717642 Free PMC article.
-
Cognitive phenotype of psychotic symptoms in Alzheimer's disease: evidence for impaired visuoperceptual function in the misidentification subtype.Int J Geriatr Psychiatry. 2015 Dec;30(12):1147-55. doi: 10.1002/gps.4265. Epub 2015 Mar 24. Int J Geriatr Psychiatry. 2015. PMID: 25809437 Free PMC article.
-
A soluble truncated tau species related to cognitive dysfunction is elevated in the brain of cognitively impaired human individuals.Sci Rep. 2020 Mar 2;10(1):3869. doi: 10.1038/s41598-020-60777-x. Sci Rep. 2020. PMID: 32123248 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical